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endoscopic stent
from her obstructive jaundice and sepsis and to
undergo open cholecystectomy safely.
INTRODUCTION CASE REPORT
A Mirizzi Type I syndrome usually occurs as the
result of gallstones impacting in the cystic duct or
Hartmann’s pouch and then causing external
compression of the common hepatic duct. It is
described as an infrequent cause of obstructive
jaundice occurring in only 0.7-1.1% of cholecys-
tectomies.
In this case report, we present a case of Mirizzi
Syndrome associated with an impacted calculus
in the gallbladder, an absent cystic duct (Hayes
Type II-G anomaly) and a coincidental common
bile duct stone. ERC diagnosed the syndrome,
defined the anatomical variation and through
interim stenting allowed the patient to recover
A 65 year old female presented with a four-day
history of abdominal pain and deepening jaun-
dice. The day prior to admission she developed
fever and rigors. Examination confirmed a deep
jaundice, moderate to severe dehydration and
tenderness in the right upper quadrant.
The blood pressure was 100/60 and she had
a pulse of 100/min. Her temperature was
38C, white cell count 4.7 (xl09/L). Platelets
84 (xl09/L), INR 1.1, APTT 27. Urea was
17.8 mmol/1 and Creatinine 0.147mmol/1. Liver
function tests; AP 97 U/L, GGT 260 U/L, ALT 45
U/L, AST 35 U/L, Bilirubin 245 tmol/1 and a
normal amylase.
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A diagnosis of ascending cholangitis was
made with potential disseminated intravascular
coagulopathy (DIC). The patient was resusci-
tated with both crystalloids and colloids. Broad
spectrum antibiotics were started and 6 packs of
platelets were given.
Ultrasonography demonstrated a single stone
in the gallbladder without any sonographic
evidence of cholecystitis. The bile duct was
measured at 10mm. The cause of patient’s
jaundice was not defined by ultrasound and
she underwent ERCP within 24 hours.
ERC demonstrated a 5mm stone in the com-
mon bile duct. Cholangiography confirmed the
stone in the gallbladder, a very short cystic duct
and a dilated common hepatic duct. Intrahepatic
ducts filled poorly. The stone in the bile duct was
thought to be the cause of the clinical presenta-
tion. A 1.5 cm sphincterotomy was done and the
stone removed from the bile duct.
The patient did not improve. Her bilirubin
remained elevated and her liver function tests
deteriorated further. A second ERC was done.
The sphincterotomy was noted to be wide open.
A stone was noted impacting the common
hepatic duct from the gallbladder (Fig. 1).
Initial attempts to pass a guide wire beyond
the calculus failed. However, using an endotor-
que guidewire (Wilson Cook), the proximal
biliary duct was negotiated. A catheter was then
passed over the wire allowing contrast into the
proximal biliary duct demonstrating the cause of
the obstruction. A 7F 12 cm stent was inserted
across the narrowed duct and free flow of
obstructed bile was noted (Fig. 2).
The patient made a rapid recovery, her jaundice
receding and her LF T’s returning to normal. The
patient remained in hospital 5 days following the
placement of the stent. Two months later she was
readmitted, for elective cholecystectomy. It was
decided to remove the stent prior to the operation,
however on removing it the stone in the gall-
bladder again obstructed the CBD, hence a new
stent was reinserted. The patient then underwent
an open cholecystectomy 3 days later, during the
same admission.
FIGURE Impaction of gallstone into the common hepatic
duct.
At operation a Hayes Type III-G abnormality
was confirmed. There was no cystic duct, just a
large calibre opening into the common bile duct.
The gallbaldder was fibrosed and Calot’s triangle
was ill defined. Acute on chronic inflammation
made a retrograde dissection necessary. The cystic
duct artery was noted branching directly off the
right hepatic artery. This was ligated in continuity
and divided. During dissection of the gallbladder
and in Calot’s triangle, the stent in the bile duct
was invaluable in providing a palpable guideline
for the position of the bile duct. Due to the absence
of a definable cystic duct, a distal rim of 0.5 cm of
gallbladder was left attached to the common bile
duct which was then oversewn with 3.0 Maxon.
The stent was left in situ in order to facilitate bile
drainage into the duodenum and prevent any bile
leakage from the cystic duct stump.
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FIGURE 2 Gallstone disimpacted and stent placed allowing
biliary drainage.
The patient made an uneventful recovery and
her stent was removed endoscopically at 1
month. At 12 months follow up there have been
no further problems.
DISCUSSION
Obstructive jaundice caused by a stone in the
cystic duct or Hartmann’s pouch is known as
Mirizzi’s Syndrome [1]. Mirizzi first described a
functional hepatic syndrome. He listed the
following as aetiological causes
(1) an anatomic variation of the cystic duct or
neck of the gallbladder adjacent to the
common hepatic duct;
(2) impaction of a stone in the cystic duct or
neck of gallbladder;
(3) partial mechanical obstruction of the com-
mon duct by the stone or by the resulting
inflammatory reaction and oedema;
(4) jaundice, recurrent cholangitis and if long-
standing, cholangitic cirrhosis [2].
McSherry [3], redefined the Mirizzi Syndrome
in 1982. Type I occurs when there is external
compression of the common hepatic duct by a
large stone impacted in the cystic duct or
Hartmann’s pouch. In Type II, a cholecystocho-
ledochal fistula is present caused by a calculus
which has eroded partly or completely into the
common hepatic duct.
Hayes [4], reviewed 400 biliary operations and
reported biliary anomalies in 189. These he
divided into four major types. Type I, accessory
ducts; Type II, anomalous length of common
hepatic duct; Type III, anomalous junction of
cystic with common hepatic duct; Type IV,
anomaly of common duct. The Type III anomaly,
into which this patient belongs, constitutes only
6 % of total anomalies in Hayes’ analysis. These
are further subdivided alphabetically, Type III-G
being an absent cystic duct.
The patient in this report was an example of
Mirizzi Type I with a Hayes Type III G anomaly.
However, it is unusual for a number of reasons.
At the time of presentation, ultrasound was
equivocal about dilatation of extrahepatic ducts,
a stone was found in the CBD and presumed to
be the cause of obstruction. However, despite its
removal the patient did not improve. At the
second ERC, the common hepatic duct was
dilated and the effect of the stone in the
gallbladder in causing a Mirizzi syndrome
became evident. In addition, the anomalous
biliary anatomy was defined and later con-
firmed at surgery.
The use of an endoscopic biliary stent in the
management of a Mirizzi Syndrome has been
previously described [5] and provides acute relief
of the obstruction whilst the patient is resusci-
tated for subsequent definitive treatment. Typi-
cally, Mirizzi syndrome produces severe, acute or
chronic changes within Calot’s triangle. It is
generally regarded that this syndrome is a contra-
indication to laparoscopic cholecystectomy.
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Open cholecystectomy can also be difficult, as it
was in this case where chronic inflammation
had eliminated normal anatomical boundaries.
We believe the insertion of a biliary stent was a
useful adjunct to open surgery. It provided a
palpable guide to the anatomical position of the
bile duct, making dissection in Calot’s triangle
less hazardous.
Anatomical variations of the biliary tree are
reported in 0.7-1.1% of patients undergoing
cholecystectomy [6, 7] and the Mirizzi Syndrome
also is infrequently encountered [8]. In this case,
the use of an endoscopic stent provided acute
relief in an acutely ill patient and allowed for the
subsequent elective approach to treatment. After
the second ERC we planned to remove the stent
and then proceed to cholecystectomy. However,
the obstruction recurredimmediately due to the
anomalous anatomy in this patient. Conse-
quently this patient needed to have her gall-
bladder operation with the endoscopic stent in
situ. At operation, the presence of the stent
proved to be of assistance in helping to define the
anatomy. The stent was removed as a day
procedure once the patient had recovered from
the open operation.
This case highlights the combination of an
endoscopic and operative approach in the
treatment of gallstones associated with an
anatomical anomaly which led to cholangitis.
An endoscopic approach was used prior to
cholecystectomy so that at the time of surgery
the patient was neither jaundiced nor had acute
cholangitis.
Data from previously published studies
[9,10,11] support an initial endoscopic approach
in the treatment of patients with cholangitis as
the morbidity and mortality is significantly
reduced when compared to a direct open
operation. Once the acute illness has subsided
it allows for treating such patients subsequently
via either a laparoscopic or as in this patient via
open cholecystectomy.
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